Showing results (101-110 of 501) with videos related to
Sort By:
Pageof 51
Elife|September 7, 2022
Highly efficient generation of isogenic pluripotent stem cell models using prime editingHanqin Li, Oriol Busquets, Yogendra Verma, et al.Cell Reports|June 30, 2021
Revealing molecular pathways for cancer cell fitness through a genetic screen of the cancer translatomeDuygu Kuzuoglu-Ozturk, Zhiqiang Hu, Martina Rama, et al.Biorxiv : the Preprint Server for Biology|June 19, 2023
ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathwaySongnan Wang, Volker Böhnert, Alby J Joseph, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 18, 2007
Effect of epidermal growth factor receptor inhibitor class in the treatment of head and neck cancer with concurrent radiochemotherapy in vivoFelix Y Feng, Carlos A Lopez, Daniel P Normolle, et al.Journal of the National Cancer Institute|October 7, 2016
Development of a RNA-Seq Based Prognostic Signature in Lung AdenocarcinomaSudhanshu Shukla, Joseph R Evans, Rohit Malik, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2023
Prostate-Specific Antigen Level at the Time of Salvage Therapy After Radical Prostatectomy for Prostate Cancer and the Risk of DeathDerya Tilki, Ming-Hui Chen, Jing Wu, et al.Neoplasia (New York, N.Y.)|April 25, 2016
MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent MannerFelix Y Feng, Yu Zhang, Vishal Kothari, et al.Cancer Research|November 6, 2021
Loss of Long Noncoding RNA <i>NXTAR</i> in Prostate Cancer Augments Androgen Receptor Expression and Enzalutamide ResistanceRuchi Ghildiyal, Mithila Sawant, Arun Renganathan, et al.Advances in Radiation Oncology|July 18, 2022
Addition of Enzalutamide to Leuprolide and Definitive Radiation Therapy Is Tolerable and Effective in High-Risk Localized or Regional Nonmetastatic Prostate Cancer: Results From a Phase 2 TrialKevin Shee, Claire M de la Calle, Albert J Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 9, 2014
A tissue biomarker-based model that identifies patients with a high risk of distant metastasis and differential survival by length of androgen deprivation therapy in RTOG protocol 92-02Alan Pollack, James J Dignam, Dayssy A Diaz, et al.Pageof 51